INFLAMMATION-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2165926, encodeId=c449216592604, content=文章被编辑拒了，说语法和写作需要improvement，然后介绍了一些润色机构，是让我润色后重新投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=336e2390613, createdName=福禄娃二号机, createdTime=Tue Oct 31 16:21:33 CST 2023, time=2023-10-31, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1229524, encodeId=e4671229524ef, content=初步审查的时候要了蛋白WB原始数据，已按要求提交，不知后续结果如何, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59476423409, createdName=ms5000001894093922, createdTime=Wed Jun 29 18:41:36 CST 2022, time=2022-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2199406, encodeId=e0792199406ad, content=这个杂志收综述吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=65861397214, createdName=chenyongdaniel, createdTime=Sat Apr 20 03:22:17 CST 2024, time=2024-04-20, status=1, ipAttribution=加利福尼亚), GetPortalCommentsPageByObjectIdResponse(id=2152415, encodeId=eeea21524155b, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：哮喘 经验分享：一审一个审稿人，小修，二审还会增加审稿人吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6b655177875, createdName=146ee135m37暂无昵称, createdTime=Sat Aug 12 12:28:31 CST 2023, time=2023-08-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2122701, encodeId=31cd2122e01e5, content=初审2个审稿人，返修回去多了一个审稿人，有这样的情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=365b6573539, createdName=ms4000000487412027, createdTime=Thu Mar 30 12:14:55 CST 2023, time=2023-03-30, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2152579, encodeId=842521525e93d, content=想请问下大家参考文献格式从哪儿找的啊 endnote官网没找着谢谢谢谢救救孩子 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad808404158, createdName=ms8000001972745472, createdTime=Sun Aug 13 18:29:22 CST 2023, time=2023-08-13, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2139068, encodeId=822c2139068c8, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：炎症 经验分享：感觉编辑很友好，审稿人很专业，问的问题都很大提升了文章的深度。审稿速度快，见刊快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bb025455737, createdName=ms7000001640624402, createdTime=Thu May 25 22:57:56 CST 2023, time=2023-05-25, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2115369, encodeId=fe7c2115369d5, content=投稿当天就显示2 reviewers accepted，是什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210527/8e5840d711c249e7a51cfc1c655ea47a/ec4983f2d6a847ad9d8830294d330f6d.jpg, createdBy=7f8e5508805, createdName=小白罢了, createdTime=Sun Feb 19 10:36:34 CST 2023, time=2023-02-19, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2117594, encodeId=28d5211e59456, content=为什么没有看到上传WB原图的地方啊？是改版了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0cf5690115, createdName=ms9000001570698815, createdTime=Sun Mar 05 00:34:30 CST 2023, time=2023-03-05, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1066067, encodeId=60e1106606e8f, content=请问这个杂志接收后多久可以proof，接收都快1个月了，还没有收到proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=27bf1524600, createdName=viviancao1981, createdTime=Tue Nov 02 01:41:50 CST 2021, time=2021-11-02, status=1, ipAttribution=)]

2023-10-31 福禄娃二号机来自重庆

文章被编辑拒了，说语法和写作需要improvement，然后介绍了一些润色机构，是让我润色后重新投吗？

79 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2165926, encodeId=c449216592604, content=文章被编辑拒了，说语法和写作需要improvement，然后介绍了一些润色机构，是让我润色后重新投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=336e2390613, createdName=福禄娃二号机, createdTime=Tue Oct 31 16:21:33 CST 2023, time=2023-10-31, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1229524, encodeId=e4671229524ef, content=初步审查的时候要了蛋白WB原始数据，已按要求提交，不知后续结果如何, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59476423409, createdName=ms5000001894093922, createdTime=Wed Jun 29 18:41:36 CST 2022, time=2022-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2199406, encodeId=e0792199406ad, content=这个杂志收综述吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=65861397214, createdName=chenyongdaniel, createdTime=Sat Apr 20 03:22:17 CST 2024, time=2024-04-20, status=1, ipAttribution=加利福尼亚), GetPortalCommentsPageByObjectIdResponse(id=2152415, encodeId=eeea21524155b, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：哮喘 经验分享：一审一个审稿人，小修，二审还会增加审稿人吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6b655177875, createdName=146ee135m37暂无昵称, createdTime=Sat Aug 12 12:28:31 CST 2023, time=2023-08-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2122701, encodeId=31cd2122e01e5, content=初审2个审稿人，返修回去多了一个审稿人，有这样的情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=365b6573539, createdName=ms4000000487412027, createdTime=Thu Mar 30 12:14:55 CST 2023, time=2023-03-30, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2152579, encodeId=842521525e93d, content=想请问下大家参考文献格式从哪儿找的啊 endnote官网没找着谢谢谢谢救救孩子 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad808404158, createdName=ms8000001972745472, createdTime=Sun Aug 13 18:29:22 CST 2023, time=2023-08-13, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2139068, encodeId=822c2139068c8, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：炎症 经验分享：感觉编辑很友好，审稿人很专业，问的问题都很大提升了文章的深度。审稿速度快，见刊快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bb025455737, createdName=ms7000001640624402, createdTime=Thu May 25 22:57:56 CST 2023, time=2023-05-25, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2115369, encodeId=fe7c2115369d5, content=投稿当天就显示2 reviewers accepted，是什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210527/8e5840d711c249e7a51cfc1c655ea47a/ec4983f2d6a847ad9d8830294d330f6d.jpg, createdBy=7f8e5508805, createdName=小白罢了, createdTime=Sun Feb 19 10:36:34 CST 2023, time=2023-02-19, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2117594, encodeId=28d5211e59456, content=为什么没有看到上传WB原图的地方啊？是改版了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0cf5690115, createdName=ms9000001570698815, createdTime=Sun Mar 05 00:34:30 CST 2023, time=2023-03-05, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1066067, encodeId=60e1106606e8f, content=请问这个杂志接收后多久可以proof，接收都快1个月了，还没有收到proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=27bf1524600, createdName=viviancao1981, createdTime=Tue Nov 02 01:41:50 CST 2021, time=2021-11-02, status=1, ipAttribution=)]

2022-06-29 ms5000001894093922

初步审查的时候要了蛋白WB原始数据，已按要求提交，不知后续结果如何

69 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=2165926, encodeId=c449216592604, content=文章被编辑拒了，说语法和写作需要improvement，然后介绍了一些润色机构，是让我润色后重新投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=336e2390613, createdName=福禄娃二号机, createdTime=Tue Oct 31 16:21:33 CST 2023, time=2023-10-31, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1229524, encodeId=e4671229524ef, content=初步审查的时候要了蛋白WB原始数据，已按要求提交，不知后续结果如何, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59476423409, createdName=ms5000001894093922, createdTime=Wed Jun 29 18:41:36 CST 2022, time=2022-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2199406, encodeId=e0792199406ad, content=这个杂志收综述吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=65861397214, createdName=chenyongdaniel, createdTime=Sat Apr 20 03:22:17 CST 2024, time=2024-04-20, status=1, ipAttribution=加利福尼亚), GetPortalCommentsPageByObjectIdResponse(id=2152415, encodeId=eeea21524155b, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：哮喘 经验分享：一审一个审稿人，小修，二审还会增加审稿人吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6b655177875, createdName=146ee135m37暂无昵称, createdTime=Sat Aug 12 12:28:31 CST 2023, time=2023-08-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2122701, encodeId=31cd2122e01e5, content=初审2个审稿人，返修回去多了一个审稿人，有这样的情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=365b6573539, createdName=ms4000000487412027, createdTime=Thu Mar 30 12:14:55 CST 2023, time=2023-03-30, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2152579, encodeId=842521525e93d, content=想请问下大家参考文献格式从哪儿找的啊 endnote官网没找着谢谢谢谢救救孩子 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad808404158, createdName=ms8000001972745472, createdTime=Sun Aug 13 18:29:22 CST 2023, time=2023-08-13, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2139068, encodeId=822c2139068c8, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：炎症 经验分享：感觉编辑很友好，审稿人很专业，问的问题都很大提升了文章的深度。审稿速度快，见刊快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bb025455737, createdName=ms7000001640624402, createdTime=Thu May 25 22:57:56 CST 2023, time=2023-05-25, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2115369, encodeId=fe7c2115369d5, content=投稿当天就显示2 reviewers accepted，是什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210527/8e5840d711c249e7a51cfc1c655ea47a/ec4983f2d6a847ad9d8830294d330f6d.jpg, createdBy=7f8e5508805, createdName=小白罢了, createdTime=Sun Feb 19 10:36:34 CST 2023, time=2023-02-19, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2117594, encodeId=28d5211e59456, content=为什么没有看到上传WB原图的地方啊？是改版了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0cf5690115, createdName=ms9000001570698815, createdTime=Sun Mar 05 00:34:30 CST 2023, time=2023-03-05, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1066067, encodeId=60e1106606e8f, content=请问这个杂志接收后多久可以proof，接收都快1个月了，还没有收到proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=27bf1524600, createdName=viviancao1981, createdTime=Tue Nov 02 01:41:50 CST 2021, time=2021-11-02, status=1, ipAttribution=)]

2024-04-20 chenyongdaniel 来自加利福尼亚

这个杂志收综述吗？

24 0

[GetPortalCommentsPageByObjectIdResponse(id=2165926, encodeId=c449216592604, content=文章被编辑拒了，说语法和写作需要improvement，然后介绍了一些润色机构，是让我润色后重新投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=336e2390613, createdName=福禄娃二号机, createdTime=Tue Oct 31 16:21:33 CST 2023, time=2023-10-31, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1229524, encodeId=e4671229524ef, content=初步审查的时候要了蛋白WB原始数据，已按要求提交，不知后续结果如何, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59476423409, createdName=ms5000001894093922, createdTime=Wed Jun 29 18:41:36 CST 2022, time=2022-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2199406, encodeId=e0792199406ad, content=这个杂志收综述吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=65861397214, createdName=chenyongdaniel, createdTime=Sat Apr 20 03:22:17 CST 2024, time=2024-04-20, status=1, ipAttribution=加利福尼亚), GetPortalCommentsPageByObjectIdResponse(id=2152415, encodeId=eeea21524155b, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：哮喘 经验分享：一审一个审稿人，小修，二审还会增加审稿人吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6b655177875, createdName=146ee135m37暂无昵称, createdTime=Sat Aug 12 12:28:31 CST 2023, time=2023-08-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2122701, encodeId=31cd2122e01e5, content=初审2个审稿人，返修回去多了一个审稿人，有这样的情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=365b6573539, createdName=ms4000000487412027, createdTime=Thu Mar 30 12:14:55 CST 2023, time=2023-03-30, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2152579, encodeId=842521525e93d, content=想请问下大家参考文献格式从哪儿找的啊 endnote官网没找着谢谢谢谢救救孩子 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad808404158, createdName=ms8000001972745472, createdTime=Sun Aug 13 18:29:22 CST 2023, time=2023-08-13, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2139068, encodeId=822c2139068c8, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：炎症 经验分享：感觉编辑很友好，审稿人很专业，问的问题都很大提升了文章的深度。审稿速度快，见刊快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bb025455737, createdName=ms7000001640624402, createdTime=Thu May 25 22:57:56 CST 2023, time=2023-05-25, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2115369, encodeId=fe7c2115369d5, content=投稿当天就显示2 reviewers accepted，是什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210527/8e5840d711c249e7a51cfc1c655ea47a/ec4983f2d6a847ad9d8830294d330f6d.jpg, createdBy=7f8e5508805, createdName=小白罢了, createdTime=Sun Feb 19 10:36:34 CST 2023, time=2023-02-19, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2117594, encodeId=28d5211e59456, content=为什么没有看到上传WB原图的地方啊？是改版了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0cf5690115, createdName=ms9000001570698815, createdTime=Sun Mar 05 00:34:30 CST 2023, time=2023-03-05, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1066067, encodeId=60e1106606e8f, content=请问这个杂志接收后多久可以proof，接收都快1个月了，还没有收到proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=27bf1524600, createdName=viviancao1981, createdTime=Tue Nov 02 01:41:50 CST 2021, time=2021-11-02, status=1, ipAttribution=)]

2023-08-12 146ee135m37暂无昵称来自广东省

审稿速度:2.0 | 投稿命中率:95.0
偏重的研究方向：哮喘
经验分享：一审一个审稿人，小修，二审还会增加审稿人吗？

72 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2165926, encodeId=c449216592604, content=文章被编辑拒了，说语法和写作需要improvement，然后介绍了一些润色机构，是让我润色后重新投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=336e2390613, createdName=福禄娃二号机, createdTime=Tue Oct 31 16:21:33 CST 2023, time=2023-10-31, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1229524, encodeId=e4671229524ef, content=初步审查的时候要了蛋白WB原始数据，已按要求提交，不知后续结果如何, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59476423409, createdName=ms5000001894093922, createdTime=Wed Jun 29 18:41:36 CST 2022, time=2022-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2199406, encodeId=e0792199406ad, content=这个杂志收综述吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=65861397214, createdName=chenyongdaniel, createdTime=Sat Apr 20 03:22:17 CST 2024, time=2024-04-20, status=1, ipAttribution=加利福尼亚), GetPortalCommentsPageByObjectIdResponse(id=2152415, encodeId=eeea21524155b, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：哮喘 经验分享：一审一个审稿人，小修，二审还会增加审稿人吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6b655177875, createdName=146ee135m37暂无昵称, createdTime=Sat Aug 12 12:28:31 CST 2023, time=2023-08-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2122701, encodeId=31cd2122e01e5, content=初审2个审稿人，返修回去多了一个审稿人，有这样的情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=365b6573539, createdName=ms4000000487412027, createdTime=Thu Mar 30 12:14:55 CST 2023, time=2023-03-30, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2152579, encodeId=842521525e93d, content=想请问下大家参考文献格式从哪儿找的啊 endnote官网没找着谢谢谢谢救救孩子 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad808404158, createdName=ms8000001972745472, createdTime=Sun Aug 13 18:29:22 CST 2023, time=2023-08-13, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2139068, encodeId=822c2139068c8, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：炎症 经验分享：感觉编辑很友好，审稿人很专业，问的问题都很大提升了文章的深度。审稿速度快，见刊快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bb025455737, createdName=ms7000001640624402, createdTime=Thu May 25 22:57:56 CST 2023, time=2023-05-25, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2115369, encodeId=fe7c2115369d5, content=投稿当天就显示2 reviewers accepted，是什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210527/8e5840d711c249e7a51cfc1c655ea47a/ec4983f2d6a847ad9d8830294d330f6d.jpg, createdBy=7f8e5508805, createdName=小白罢了, createdTime=Sun Feb 19 10:36:34 CST 2023, time=2023-02-19, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2117594, encodeId=28d5211e59456, content=为什么没有看到上传WB原图的地方啊？是改版了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0cf5690115, createdName=ms9000001570698815, createdTime=Sun Mar 05 00:34:30 CST 2023, time=2023-03-05, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1066067, encodeId=60e1106606e8f, content=请问这个杂志接收后多久可以proof，接收都快1个月了，还没有收到proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=27bf1524600, createdName=viviancao1981, createdTime=Tue Nov 02 01:41:50 CST 2021, time=2021-11-02, status=1, ipAttribution=)]

2023-03-30 ms4000000487412027 来自浙江省

初审2个审稿人，返修回去多了一个审稿人，有这样的情况吗

76 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2165926, encodeId=c449216592604, content=文章被编辑拒了，说语法和写作需要improvement，然后介绍了一些润色机构，是让我润色后重新投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=336e2390613, createdName=福禄娃二号机, createdTime=Tue Oct 31 16:21:33 CST 2023, time=2023-10-31, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1229524, encodeId=e4671229524ef, content=初步审查的时候要了蛋白WB原始数据，已按要求提交，不知后续结果如何, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59476423409, createdName=ms5000001894093922, createdTime=Wed Jun 29 18:41:36 CST 2022, time=2022-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2199406, encodeId=e0792199406ad, content=这个杂志收综述吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=65861397214, createdName=chenyongdaniel, createdTime=Sat Apr 20 03:22:17 CST 2024, time=2024-04-20, status=1, ipAttribution=加利福尼亚), GetPortalCommentsPageByObjectIdResponse(id=2152415, encodeId=eeea21524155b, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：哮喘 经验分享：一审一个审稿人，小修，二审还会增加审稿人吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6b655177875, createdName=146ee135m37暂无昵称, createdTime=Sat Aug 12 12:28:31 CST 2023, time=2023-08-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2122701, encodeId=31cd2122e01e5, content=初审2个审稿人，返修回去多了一个审稿人，有这样的情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=365b6573539, createdName=ms4000000487412027, createdTime=Thu Mar 30 12:14:55 CST 2023, time=2023-03-30, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2152579, encodeId=842521525e93d, content=想请问下大家参考文献格式从哪儿找的啊 endnote官网没找着谢谢谢谢救救孩子 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad808404158, createdName=ms8000001972745472, createdTime=Sun Aug 13 18:29:22 CST 2023, time=2023-08-13, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2139068, encodeId=822c2139068c8, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：炎症 经验分享：感觉编辑很友好，审稿人很专业，问的问题都很大提升了文章的深度。审稿速度快，见刊快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bb025455737, createdName=ms7000001640624402, createdTime=Thu May 25 22:57:56 CST 2023, time=2023-05-25, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2115369, encodeId=fe7c2115369d5, content=投稿当天就显示2 reviewers accepted，是什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210527/8e5840d711c249e7a51cfc1c655ea47a/ec4983f2d6a847ad9d8830294d330f6d.jpg, createdBy=7f8e5508805, createdName=小白罢了, createdTime=Sun Feb 19 10:36:34 CST 2023, time=2023-02-19, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2117594, encodeId=28d5211e59456, content=为什么没有看到上传WB原图的地方啊？是改版了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0cf5690115, createdName=ms9000001570698815, createdTime=Sun Mar 05 00:34:30 CST 2023, time=2023-03-05, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1066067, encodeId=60e1106606e8f, content=请问这个杂志接收后多久可以proof，接收都快1个月了，还没有收到proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=27bf1524600, createdName=viviancao1981, createdTime=Tue Nov 02 01:41:50 CST 2021, time=2021-11-02, status=1, ipAttribution=)]

2023-08-13 ms8000001972745472 来自河南省

想请问下大家参考文献格式从哪儿找的啊 endnote官网没找着谢谢谢谢救救孩子

53 0

[GetPortalCommentsPageByObjectIdResponse(id=2165926, encodeId=c449216592604, content=文章被编辑拒了，说语法和写作需要improvement，然后介绍了一些润色机构，是让我润色后重新投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=336e2390613, createdName=福禄娃二号机, createdTime=Tue Oct 31 16:21:33 CST 2023, time=2023-10-31, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1229524, encodeId=e4671229524ef, content=初步审查的时候要了蛋白WB原始数据，已按要求提交，不知后续结果如何, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59476423409, createdName=ms5000001894093922, createdTime=Wed Jun 29 18:41:36 CST 2022, time=2022-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2199406, encodeId=e0792199406ad, content=这个杂志收综述吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=65861397214, createdName=chenyongdaniel, createdTime=Sat Apr 20 03:22:17 CST 2024, time=2024-04-20, status=1, ipAttribution=加利福尼亚), GetPortalCommentsPageByObjectIdResponse(id=2152415, encodeId=eeea21524155b, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：哮喘 经验分享：一审一个审稿人，小修，二审还会增加审稿人吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6b655177875, createdName=146ee135m37暂无昵称, createdTime=Sat Aug 12 12:28:31 CST 2023, time=2023-08-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2122701, encodeId=31cd2122e01e5, content=初审2个审稿人，返修回去多了一个审稿人，有这样的情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=365b6573539, createdName=ms4000000487412027, createdTime=Thu Mar 30 12:14:55 CST 2023, time=2023-03-30, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2152579, encodeId=842521525e93d, content=想请问下大家参考文献格式从哪儿找的啊 endnote官网没找着谢谢谢谢救救孩子 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad808404158, createdName=ms8000001972745472, createdTime=Sun Aug 13 18:29:22 CST 2023, time=2023-08-13, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2139068, encodeId=822c2139068c8, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：炎症 经验分享：感觉编辑很友好，审稿人很专业，问的问题都很大提升了文章的深度。审稿速度快，见刊快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bb025455737, createdName=ms7000001640624402, createdTime=Thu May 25 22:57:56 CST 2023, time=2023-05-25, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2115369, encodeId=fe7c2115369d5, content=投稿当天就显示2 reviewers accepted，是什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210527/8e5840d711c249e7a51cfc1c655ea47a/ec4983f2d6a847ad9d8830294d330f6d.jpg, createdBy=7f8e5508805, createdName=小白罢了, createdTime=Sun Feb 19 10:36:34 CST 2023, time=2023-02-19, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2117594, encodeId=28d5211e59456, content=为什么没有看到上传WB原图的地方啊？是改版了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0cf5690115, createdName=ms9000001570698815, createdTime=Sun Mar 05 00:34:30 CST 2023, time=2023-03-05, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1066067, encodeId=60e1106606e8f, content=请问这个杂志接收后多久可以proof，接收都快1个月了，还没有收到proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=27bf1524600, createdName=viviancao1981, createdTime=Tue Nov 02 01:41:50 CST 2021, time=2021-11-02, status=1, ipAttribution=)]

2023-05-25 ms7000001640624402 来自浙江省

审稿速度:1.0 | 投稿命中率:50.0
偏重的研究方向：炎症
经验分享：感觉编辑很友好，审稿人很专业，问的问题都很大提升了文章的深度。审稿速度快，见刊快。

57 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2165926, encodeId=c449216592604, content=文章被编辑拒了，说语法和写作需要improvement，然后介绍了一些润色机构，是让我润色后重新投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=336e2390613, createdName=福禄娃二号机, createdTime=Tue Oct 31 16:21:33 CST 2023, time=2023-10-31, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1229524, encodeId=e4671229524ef, content=初步审查的时候要了蛋白WB原始数据，已按要求提交，不知后续结果如何, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59476423409, createdName=ms5000001894093922, createdTime=Wed Jun 29 18:41:36 CST 2022, time=2022-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2199406, encodeId=e0792199406ad, content=这个杂志收综述吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=65861397214, createdName=chenyongdaniel, createdTime=Sat Apr 20 03:22:17 CST 2024, time=2024-04-20, status=1, ipAttribution=加利福尼亚), GetPortalCommentsPageByObjectIdResponse(id=2152415, encodeId=eeea21524155b, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：哮喘 经验分享：一审一个审稿人，小修，二审还会增加审稿人吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6b655177875, createdName=146ee135m37暂无昵称, createdTime=Sat Aug 12 12:28:31 CST 2023, time=2023-08-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2122701, encodeId=31cd2122e01e5, content=初审2个审稿人，返修回去多了一个审稿人，有这样的情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=365b6573539, createdName=ms4000000487412027, createdTime=Thu Mar 30 12:14:55 CST 2023, time=2023-03-30, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2152579, encodeId=842521525e93d, content=想请问下大家参考文献格式从哪儿找的啊 endnote官网没找着谢谢谢谢救救孩子 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad808404158, createdName=ms8000001972745472, createdTime=Sun Aug 13 18:29:22 CST 2023, time=2023-08-13, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2139068, encodeId=822c2139068c8, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：炎症 经验分享：感觉编辑很友好，审稿人很专业，问的问题都很大提升了文章的深度。审稿速度快，见刊快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bb025455737, createdName=ms7000001640624402, createdTime=Thu May 25 22:57:56 CST 2023, time=2023-05-25, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2115369, encodeId=fe7c2115369d5, content=投稿当天就显示2 reviewers accepted，是什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210527/8e5840d711c249e7a51cfc1c655ea47a/ec4983f2d6a847ad9d8830294d330f6d.jpg, createdBy=7f8e5508805, createdName=小白罢了, createdTime=Sun Feb 19 10:36:34 CST 2023, time=2023-02-19, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2117594, encodeId=28d5211e59456, content=为什么没有看到上传WB原图的地方啊？是改版了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0cf5690115, createdName=ms9000001570698815, createdTime=Sun Mar 05 00:34:30 CST 2023, time=2023-03-05, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1066067, encodeId=60e1106606e8f, content=请问这个杂志接收后多久可以proof，接收都快1个月了，还没有收到proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=27bf1524600, createdName=viviancao1981, createdTime=Tue Nov 02 01:41:50 CST 2021, time=2021-11-02, status=1, ipAttribution=)]

2023-02-19 小白罢了来自辽宁省

投稿当天就显示2 reviewers accepted，是什么情况

61 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2165926, encodeId=c449216592604, content=文章被编辑拒了，说语法和写作需要improvement，然后介绍了一些润色机构，是让我润色后重新投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=336e2390613, createdName=福禄娃二号机, createdTime=Tue Oct 31 16:21:33 CST 2023, time=2023-10-31, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1229524, encodeId=e4671229524ef, content=初步审查的时候要了蛋白WB原始数据，已按要求提交，不知后续结果如何, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59476423409, createdName=ms5000001894093922, createdTime=Wed Jun 29 18:41:36 CST 2022, time=2022-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2199406, encodeId=e0792199406ad, content=这个杂志收综述吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=65861397214, createdName=chenyongdaniel, createdTime=Sat Apr 20 03:22:17 CST 2024, time=2024-04-20, status=1, ipAttribution=加利福尼亚), GetPortalCommentsPageByObjectIdResponse(id=2152415, encodeId=eeea21524155b, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：哮喘 经验分享：一审一个审稿人，小修，二审还会增加审稿人吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6b655177875, createdName=146ee135m37暂无昵称, createdTime=Sat Aug 12 12:28:31 CST 2023, time=2023-08-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2122701, encodeId=31cd2122e01e5, content=初审2个审稿人，返修回去多了一个审稿人，有这样的情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=365b6573539, createdName=ms4000000487412027, createdTime=Thu Mar 30 12:14:55 CST 2023, time=2023-03-30, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2152579, encodeId=842521525e93d, content=想请问下大家参考文献格式从哪儿找的啊 endnote官网没找着谢谢谢谢救救孩子 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad808404158, createdName=ms8000001972745472, createdTime=Sun Aug 13 18:29:22 CST 2023, time=2023-08-13, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2139068, encodeId=822c2139068c8, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：炎症 经验分享：感觉编辑很友好，审稿人很专业，问的问题都很大提升了文章的深度。审稿速度快，见刊快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bb025455737, createdName=ms7000001640624402, createdTime=Thu May 25 22:57:56 CST 2023, time=2023-05-25, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2115369, encodeId=fe7c2115369d5, content=投稿当天就显示2 reviewers accepted，是什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210527/8e5840d711c249e7a51cfc1c655ea47a/ec4983f2d6a847ad9d8830294d330f6d.jpg, createdBy=7f8e5508805, createdName=小白罢了, createdTime=Sun Feb 19 10:36:34 CST 2023, time=2023-02-19, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2117594, encodeId=28d5211e59456, content=为什么没有看到上传WB原图的地方啊？是改版了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0cf5690115, createdName=ms9000001570698815, createdTime=Sun Mar 05 00:34:30 CST 2023, time=2023-03-05, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1066067, encodeId=60e1106606e8f, content=请问这个杂志接收后多久可以proof，接收都快1个月了，还没有收到proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=27bf1524600, createdName=viviancao1981, createdTime=Tue Nov 02 01:41:50 CST 2021, time=2021-11-02, status=1, ipAttribution=)]

2023-03-05 ms9000001570698815 来自湖北省

为什么没有看到上传WB原图的地方啊？是改版了吗？

57 0

[GetPortalCommentsPageByObjectIdResponse(id=2165926, encodeId=c449216592604, content=文章被编辑拒了，说语法和写作需要improvement，然后介绍了一些润色机构，是让我润色后重新投吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=336e2390613, createdName=福禄娃二号机, createdTime=Tue Oct 31 16:21:33 CST 2023, time=2023-10-31, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1229524, encodeId=e4671229524ef, content=初步审查的时候要了蛋白WB原始数据，已按要求提交，不知后续结果如何, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59476423409, createdName=ms5000001894093922, createdTime=Wed Jun 29 18:41:36 CST 2022, time=2022-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2199406, encodeId=e0792199406ad, content=这个杂志收综述吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=65861397214, createdName=chenyongdaniel, createdTime=Sat Apr 20 03:22:17 CST 2024, time=2024-04-20, status=1, ipAttribution=加利福尼亚), GetPortalCommentsPageByObjectIdResponse(id=2152415, encodeId=eeea21524155b, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：哮喘 经验分享：一审一个审稿人，小修，二审还会增加审稿人吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6b655177875, createdName=146ee135m37暂无昵称, createdTime=Sat Aug 12 12:28:31 CST 2023, time=2023-08-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2122701, encodeId=31cd2122e01e5, content=初审2个审稿人，返修回去多了一个审稿人，有这样的情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=365b6573539, createdName=ms4000000487412027, createdTime=Thu Mar 30 12:14:55 CST 2023, time=2023-03-30, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2152579, encodeId=842521525e93d, content=想请问下大家参考文献格式从哪儿找的啊 endnote官网没找着谢谢谢谢救救孩子 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad808404158, createdName=ms8000001972745472, createdTime=Sun Aug 13 18:29:22 CST 2023, time=2023-08-13, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2139068, encodeId=822c2139068c8, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：炎症 经验分享：感觉编辑很友好，审稿人很专业，问的问题都很大提升了文章的深度。审稿速度快，见刊快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bb025455737, createdName=ms7000001640624402, createdTime=Thu May 25 22:57:56 CST 2023, time=2023-05-25, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2115369, encodeId=fe7c2115369d5, content=投稿当天就显示2 reviewers accepted，是什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210527/8e5840d711c249e7a51cfc1c655ea47a/ec4983f2d6a847ad9d8830294d330f6d.jpg, createdBy=7f8e5508805, createdName=小白罢了, createdTime=Sun Feb 19 10:36:34 CST 2023, time=2023-02-19, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2117594, encodeId=28d5211e59456, content=为什么没有看到上传WB原图的地方啊？是改版了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0cf5690115, createdName=ms9000001570698815, createdTime=Sun Mar 05 00:34:30 CST 2023, time=2023-03-05, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1066067, encodeId=60e1106606e8f, content=请问这个杂志接收后多久可以proof，接收都快1个月了，还没有收到proof, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=27bf1524600, createdName=viviancao1981, createdTime=Tue Nov 02 01:41:50 CST 2021, time=2021-11-02, status=1, ipAttribution=)]

2021-11-02 viviancao1981

请问这个杂志接收后多久可以proof，接收都快1个月了，还没有收到proof

101 4

展开4条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务